Element Biosciences key facts
as of Oct 2026- Developer of genetic analysis tools intended to be used for the research and diagnostic markets.
- Element Biosciences is valued at approximately $1.0B as of Oct 2026, per PrivateMarketView’s mark.
- It has raised $683.3M across 2 recorded rounds; the latest was Later Stage VC (Series D) ($277.0M) in Jul 2024.
- Notable investors include Fidelity Management & Research Company, RA Capital Management, CONNECT(San Diego), Alexandria Venture Investments, Venrock — 15 tracked in total.
- 3 institutional filers report fund marks on Element Biosciences across 37 filings.
- Status: Privately Held (backing).
Nothing comparable since the round — shown at its Series D, Jul 2024 ($1.0B post-money).
- ·The complete investor list: 15 names
- ·Watch Element Biosciences: the Monday email on marks, rounds and moves
Institutional fund marks on Element Biosciences
3 filers · latest Jul 20263 SEC-registered funds reported 37 fair-value marks on Element Biosciences between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
Element Biosciences funding rounds
2 roundsWho backs Element Biosciences
15+Element Biosciences valuation
Element Biosciences is valued at approximately $1 billion as of Oct 2026. The figure is set by institutional fund marks. The reference point is its Series D in Jul 2024, at a $1 billion post-money valuation.
Recent activity
In the last 90 days, Element Biosciences's record added 2 institutional fund marks (latest period Jul 2026).
How much has Element Biosciences raised?
Element Biosciences has raised $683 million across 2 recorded rounds since 2021. The largest was a $277 million Series D in Jul 2024.
Institutional holders and vehicles
3 SEC-registered funds reported 37 fair-value marks on Element Biosciences between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Element Biosciences investors
15 investors are on record for Element Biosciences, including Fidelity Management & Research Company, RA Capital Management, CONNECT(San Diego) and Alexandria Venture Investments. By type, the record holds 4 venture capital firms and 3 asset managers. The Series D in Jul 2024 drew 5 investors.
Comparable companies
Comparable other healthcare technology systems names by valuation on PrivateMarketView: Carbon Health ($1.3 billion), Zocdoc ($446 million) and Paradigm Health (Healthcare Technology Systems) ($443 million).
About Element Biosciences
Developer of genetic analysis tools intended to be used for the research and diagnostic markets. The company's technology develops a modular and high-performing DNA sequencing platform that will deliver quality data, workflow flexibility, and make next-generation sequencing technology more accessible, enabling medical researchers to benefit from and improve their research.
- Industry
- Other Healthcare Technology Systems
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2017
- Employees
- 407
- Website
- elementbiosciences.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.